- The FDA expanded approval for Merck's vaccine, while Robert F. Kennedy Jr. disbanded the ACIP committee.
- FDA reviewed Moderna's mRNA influenza vaccine application while Robert F. Kennedy Jr. criticized vaccine use and contracts.
Robert F. Kennedy Jr. collaborated on major cancer vaccine trials while criticizing mRNA technology and its potential funding.
2 reports, 2 independent
Updated Sep 6
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Robert F. Kennedy Jr. collaborated on major cancer vaccine trials while criticizing mRNA technology and its potential funding.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.RFK Jr. announced clinical success in personalized mRNA vaccines and plans to shut down future mRNA projects.1 source
RFK Jr. collaborated on cancer vaccine trials and criticized mRNA technology's funding.1 source
Keep exploring
The entities involved
-
Robert F. Kennedy Jr.
American politician, environmental lawyer, anti-vaccine activist, and conspiracy theorist (born 1954)
-
Moderna
American biotechnology company
-
Merck
public company in Indonesia
Related events
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.
- Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.
- Moderna and BioNTech are recognized as leaders in the personalized cancer vaccine space.
- Merck participates in a cancer vaccine study, with a researcher based at MD Anderson Cancer Center in Houston.
- The European Medicines Agency is reviewing mRNA vaccine trials reported by Moderna and MSD.